Thank you b2 so going back to the chairman's statement about efficacy seen in both indications does this mean they are seeing efficacy in tnbc and SGC clear mud isnt it
When the chairman makes an opening statement and states both indications are seeing efficacy in phase 1b should one assume this is SGC and TNBC or SGC and STS or STS and TNBC it's very confusing isn't it considering Avacta have advised their are 3 indications in phase 1b
A deal announced today was a lot to expect considering CC has only just employed staff to do the deals it seems and you could argue simon bennet and ddh were employed to achieve the same outcome
I do hope he has been brought in to advise on an ongoing deal avacta are working on eg brought in for something avacta are already working on with a third party
This will only confuse matters guys car-t and another trial is the last thing avacta need there has to be a full and complete update regarding funding ava6000 anything less is unacceptable for me
I expect to be disappointed that why I shall order in a bottle of chateau neuf du pap to accompany the business update video and perhaps some cheese twists
Disappointed not to receive a quarterly update yet avacta really needs to close some deals to dlfund this project anything less in the business update will be unacceptable for me